Filing Details

Accession Number:
0001209191-20-044753
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-08-04 17:18:14
Reporting Period:
2020-08-03
Accepted Time:
2020-08-04 17:18:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1124140 Exact Sciences Corp EXAS Services-Commercial Physical & Biological Research (8731) 204782291
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1306119 T Kevin Conroy C/O Exact Sciences Corp.
5505 Endeavor Lane
Madison WI 53719
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-04-30 501 $42.44 993,464 No 5 A Direct
Common Stock Disposition 2020-08-03 25,000 $93.79 968,464 No 4 S Direct
Common Stock Disposition 2020-08-03 198 $95.00 968,266 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 A Direct
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 26,305 Indirect Held in 401(k) Plan
Common Stock 21,730 Indirect Held in Grantor Retained Annuity Trust
Common Stock 21,730 Indirect Held in Grantor Retained Annuity Trust
Common Stock 21,729 Indirect Held in Grantor Retained Annuity Trust
Footnotes
  1. Represents shares of common stock purchased through Employee Stock Purchase Plan.
  2. The sale reported in this field was effected pursuant to a Rule 10b5-1 trading plan, which trading plan was disclosed via Form 8-K filed by Exact Sciences Corporation with the U.S. Securities and Exchange Commission on November 27, 2019.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.50 to$94.30, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation,or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separateprice within the ranges set forth in this Footnote.
  4. In addition to the shares of Common Stock reported on this Form 4, which total 1,059,760 shares, Mr. Conroy also holds, in the aggregate, an additional 1,279,310 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.